¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

±¸Á¶½ÉÁúȯ¿¬±¸È¸ The 6th K-SCI(Korea Structural Cardiovascular Intervention) Symposium : 2023-06-03

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 

±¸Á¶½ÉÁúȯ¿¬±¸È¸ The 6th K-SCI(Korea Structural Cardiovascular Intervention) Symposium : 2023-06-03
±³À°ÀÏÀÚ : 2023-06-03
±³À°Àå¼Ò : ºÎ»ê BEXCO, Á¦2Àü½ÃÀå 3F

±³À°ÁÖÁ¦ : The 6th K-SCI(Korea Structural Cardiovascular Intervention) Symposium

ÁÖÃÖ±â°ü : ´ëÇѽÉÇ÷°üÁßÀçÇÐȸ
½ÃÇà±â°ü(ÁöºÎ/°ú) : ±¸Á¶½ÉÁúȯ¿¬±¸È¸

´ã´çÀÚ : Á¶¿¹¸®
¿¬¶ôó : 02-582-8222

À̸ÞÀÏ : yehc@kscvi.org

±³À°Á¾·ù : ³»°ú

Âü¼®¿¹»óÀÎ : 100¸í
Èñ¸ÁÆòÁ¡ : 6Á¡

Áö¿ª : ºÎ»ê±¤¿ª½Ã
±³À°½Ã°£ : 6 ½Ã°£ 20ºÐ

¼¼ºÎ¼ö°­·á : 120,000¿ø  

ºñ°í -Á¤È¸¿ø ¹«·á µî·Ï -Àü¹®ÀÇ/°³¿øÀÇ/ÀϹÝÀÇ: 60,000 -ÀüÀÓÀÇ/Àü°øÀÇ: 30,000 -°£È£»ç/ÀÇ·á±â»ç/ÀÇ´ë»ý/±ºÀÇ°ü/°øÁߺ¸°ÇÀÇ/ÀÓ»óº´¸®»ç/Àǹ«±â·Ï»ç: 20,000 -»ê¾÷ü/±âŸ: 120,000 * ÇöÀåµî·Ï¸¸ °¡´ÉÇÕ´Ï´Ù.


±¸ºÐ ¿ùÀÏ °­ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ

±³À°½Ã°£ 06¿ù 03ÀÏ Á¦2Àü½ÃÀå 3F 09:00~09:18 (Ãʷϱ¸¿¬¹ßÇ¥) TAVR(Transcatheter Aortic Valve Replacement) in Asymptomatic, Moderate AS(Aortic Stenosis) or Severe AR(Aortic Regurgitation) °­ÁöÈÆ(¼­¿ïÀÇ´ë)

±³À°½Ã°£ 06¿ù 03ÀÏ Á¦2Àü½ÃÀå 3F 09:18~09:36 (Ãʷϱ¸¿¬¹ßÇ¥) PASCAL System - New Kids in TEER(Transcatheter Edge to Edge Repair) ¾ÈÁØÈ£(Àü³²ÀÇ´ë)

±³À°½Ã°£ 06¿ù 03ÀÏ Á¦2Àü½ÃÀå 3F 09:36~09:54 (Ãʷϱ¸¿¬¹ßÇ¥) Triclip - Lessons from the TRILUMINATE Pivotal Study ±è¿õ(¿µ³²ÀÇ´ë)

±³À°½Ã°£ 06¿ù 03ÀÏ Á¦2Àü½ÃÀå 3F 09:54~10:12 (Ãʷϱ¸¿¬¹ßÇ¥) TMVR(Transcatheter Mitral Valve Repair) – SAPIEN M3, INTREPID, TENDYNE, ALTAVALVE, Cehea ÀÌöÇö(°è¸íÀÇ´ë)

±³À°½Ã°£ 06¿ù 03ÀÏ Á¦2Àü½ÃÀå 3F 10:12~10:30 (Ãʷϱ¸¿¬¹ßÇ¥) Is NobleStitch Game Changer in PFO(Patent Foramen Ovale) Closure? ÀÌ»ó¿±(Áß¾ÓÀÇ´ë)

ÈÞ½Ä 06¿ù 03ÀÏ 10:30~10:50 Coffee Break ()

±³À°½Ã°£ 06¿ù 03ÀÏ Á¦2Àü½ÃÀå 3F 10:50~11:10 (Ãʷϱ¸¿¬¹ßÇ¥) New Devices in TAVR(Transcatheter Aortic Valve Replacement) Ȳº´Èñ(°¡Å縯ÀÇ´ë)

±³À°½Ã°£ 06¿ù 03ÀÏ Á¦2Àü½ÃÀå 3F 11:10~11:30 (Ãʷϱ¸¿¬¹ßÇ¥) TEE(Transesophageal Echocardiography), ICE(Intracardiac Echocardiography), TTE(Transthoracic Echocardiography): Which Is the Best in TAVR(Transcatheter Aortic Valve Replacement) °íÀ±¼®(ÇѸ²ÀÇ´ë)

±³À°½Ã°£ 06¿ù 03ÀÏ Á¦2Àü½ÃÀå 3F 11:30~11:50 (Ãʷϱ¸¿¬¹ßÇ¥) Cerebral Embolic Protection: How to Implant Step by Step ¹Ú´ö¿ì(¿ï»êÀÇ´ë)

±³À°½Ã°£ 06¿ù 03ÀÏ Á¦2Àü½ÃÀå 3F 11:50~12:10 (Ãʷϱ¸¿¬¹ßÇ¥) Valve in Valve: Patient Selection, Device Selection, What Is Different from Coventional TAVR(Transcatheter Aortic Valve Replacement)? ±èÁÖÇÑ(Àü³²ÀÇ´ë)

±³À°½Ã°£ 06¿ù 03ÀÏ Á¦2Àü½ÃÀå 3F 12:10~12:25 (Ãʷϱ¸¿¬¹ßÇ¥) Role of Prasugrel in Patients Undergoing Emergent as well as Elective PCI(Percutaneous Coronary Intervention) ÇÑÁÖ¿ë(¼º±Õ°üÀÇ´ë)

±³À°½Ã°£ 06¿ù 03ÀÏ Á¦2Àü½ÃÀå 3F 12:25~12:40 (Ãʷϱ¸¿¬¹ßÇ¥) First-line Drugs for Hypertension ±è´ëÈñ(¿ï»êÀÇ´ë)

Åä·Ð 06¿ù 03ÀÏ Á¦2Àü½ÃÀå 3F 12:40~12:50 Discussion ()

ÈÞ½Ä 06¿ù 03ÀÏ 12:50~13:10 Coffee Break ()

±³À°½Ã°£ 06¿ù 03ÀÏ Á¦2Àü½ÃÀå 3F 13:10~13:25 (Ãʷϱ¸¿¬¹ßÇ¥) Imaging Screening for Mitral TEER(Transcatheter Edge to Edge Repair) Á¶Àͼº(¿¬¼¼ÀÇ´ë)

±³À°½Ã°£ 06¿ù 03ÀÏ Á¦2Àü½ÃÀå 3F 13:25~13:40 (Ãʷϱ¸¿¬¹ßÇ¥) Device Selection for Mitral TEER(Transcatheter Edge to Edge Repair) - What Type for Individual Pathologies Á¤¿ì¹é(°¡Å縯ÀÇ´ë)

±³À°½Ã°£ 06¿ù 03ÀÏ Á¦2Àü½ÃÀå 3F 13:40~13:55 (Ãʷϱ¸¿¬¹ßÇ¥) Anatomy, Indications, and Outcomes for Tricuspid TEER(Transcatheter Edge to Edge Repair) for Incomplete Coaptation °­µµÀ±(¿ï»êÀÇ´ë)

±³À°½Ã°£ 06¿ù 03ÀÏ Á¦2Àü½ÃÀå 3F 13:55~14:10 (Ãʷϱ¸¿¬¹ßÇ¥) Is Alfieri's Technique Effective and Safe? - Surgeon's View Á¦Çü°ï(ºÎ»êÀÇ´ë)

Åä·Ð 06¿ù 03ÀÏ Á¦2Àü½ÃÀå 3F 14:10~14:30 Discussion ()

ÈÞ½Ä 06¿ù 03ÀÏ 14:30~14:40 Coffee Break ()

±³À°½Ã°£ 06¿ù 03ÀÏ Á¦2Àü½ÃÀå 3F 14:40~14:58 (Ãʷϱ¸¿¬¹ßÇ¥) Current Available and Upcoming LAA(Left Atrial Appendage) Occluder Device in Korea ÀÌÇöÁ¾(ºÎõ¼¼Á¾º´¿ø)

±³À°½Ã°£ 06¿ù 03ÀÏ Á¦2Àü½ÃÀå 3F 14:58~15:16 (Ãʷϱ¸¿¬¹ßÇ¥) Current Use of LAA(Left Atrial Appendage) Occluder in US, Japan, Korea and Future Perspectives ½Å½Â¿ë(Áß¾ÓÀÇ´ë)

±³À°½Ã°£ 06¿ù 03ÀÏ Á¦2Àü½ÃÀå 3F 15:16~15:34 (Ãʷϱ¸¿¬¹ßÇ¥) How to Minimize and Manage Device Related Thrombosis ÀÌ¿ÀÇö(¿¬¼¼ÀÇ´ë)

±³À°½Ã°£ 06¿ù 03ÀÏ Á¦2Àü½ÃÀå 3F 15:34~15:52 (Ãʷϱ¸¿¬¹ßÇ¥)Anticoagulant Regimens Post-LAA(Left Atrial Appendage) Closure ±èÈ«³â(°æºÏÀÇ´ë)

±³À°½Ã°£ 06¿ù 03ÀÏ Á¦2Àü½ÃÀå 3F 15:52~16:10 (Ãʷϱ¸¿¬¹ßÇ¥) Surgical LAA(Left Atrial Appendage) Closure - Surgeon's View Á¤µ¿¼·(¼º±Õ°üÀÇ´ë)

 

ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" ±¸Á¶½ÉÁúȯ¿¬±¸È¸ The 6th K-SCI(Korea Structural Cardiovascular Intervention) Symposium : 2023-06-03""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û ´ëÇѿ°èÁٱ⼼Æ÷Àç»ýÀÇÇÐȸ - Á¦8ȸ Live Surgery Symposium : 2023-06-03
´ÙÀ½±Û (¿Â¶óÀÎ) Á¦ 51Â÷ ´ëÇѼҾƽŰæ¹ß´ÞÇൿ¿¬±¸È¸ ÇмúÁý´ãȸ : 2023-06-03
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
20925 ÀüºÏ Á¦ 53Â÷ ´ëÇѳëÀκ´ÇÐȸ È£³²Áöȸ ÇмúÁý´äȸ : 2024-07-27 0 50 2024-05-28
20924 ¼­¿ï 2024 Á¦27ȸ ´ëÇѾȸ鼺ÇüÀç°ÇÇÐȸ Ãá°è Çмú´ëȸ : 2024-07-21 0 44 2024-05-28
20923 °æ±â 2024³â ÀÏ»ê¹éº´¿ø Á¤Çü¿Ü°ú ½ÉÆ÷Áö¾ö : 2024-07-21 0 45 2024-05-28
20922 ¼­¿ï 2024³â ü°èÀû ¹®Çå°íÂû(¸ÞŸºÐ¼®) ³í¹®Ãâ°£ ¿öÅ©¼¥ 2Â÷(2ÀÏÂ÷) : 2024-07-20 0 52 2024-05-28
20921 ¼­¿ï Á¦33Â÷ ´ç´¢º´ ¿¬±¸ ÇÏ°è¿öÅ©¼¥ : 2024-07-20 0 39 2024-05-28
20920 ¼­¿ï ´ëÇÑÁ¾¾ç³»°úÇÐȸ Recent updates in GU Cancers 2024 : 2024-07-19 0 76 2024-05-28
20919 ¼­¿ï 2024³â ü°èÀû ¹®Çå°íÂû(¸ÞŸºÐ¼®) ³í¹®Ãâ°£ ¿öÅ©¼¥ 2Â÷(1ÀÏÂ÷) : 2024-07-19 0 29 2024-05-28
20918 ¼­¿ï [¿Â¶óÀÎ] Áø´Ü¿ë ¹æ»ç¼± ¾ÈÀü°ü¸®Ã¥ÀÓÀÚ ¼±ÀÓ±³À° : 2024-07-14 0 45 2024-05-28
20917 °æºÏ 2024³â ´ëÇÑ°ñ´Ù°øÁõÇÐȸ ¿µ³² ¿¬¼ö°­Á : 2024-07-14 0 39 2024-05-28
20916 °æ±â ÀÎÁ¦´ëÇб³ ÀÏ»ê¹éº´¿ø ¼ÒÈ­±â³»°ú °³¿øÀÇ ¿¬¼ö°­Á : 2024-07-13 0 47 2024-05-28
20915 °æ±â 2024³â ÀÇÁ¤ºÎÀ»Áö´ëÇб³º´¿ø Á¦1ȸ ½Å°æ°ú °³¿øÀÇ ¿¬¼ö±³À° : 2024-07-13 0 48 2024-05-28
20914 ºÎ»ê Á¦6ȸ ºÎ»ê¼º¸ðº´¿ø ¼Ò¾Æû¼Ò³â°ú ½ÉÆ÷Áö¾ö : 2024-07-13 0 33 2024-05-28
20913 ¼­¿ï 2024 ´ëÇѽŰ泻ºÐºñ¿¬±¸È¸ ¿¬¼ö°­Á : 2024-07-13 0 37 2024-05-28
20912 ¼­¿ï ÀºÆò±¸ÀÇ»çȸ Á¦3Â÷¿¬¼ö±³À° : 2024-07-11 0 44 2024-05-28
20911 ¼­¿ï (¿Â¶óÀÎ) 2024³â ¼Ò¾Æ½ÅÀå Post-graduate education course : 2024-07-08 0 46 2024-05-28
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷